AZD2014 and Fulvestrant in Patients With ER+ Advanced Metastatic Breast Cancer

This study is currently recruiting participants. (see Contacts and Locations)

Verified February 2015 by AstraZeneca

Sponsor:

Information provided by (Responsible Party):

AstraZeneca

ClinicalTrials.gov Identifier:

NCT01597388

First received: March 28, 2012

Last updated: February 20, 2015

Last verified: February 2015

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	January 2016
Estimated Primary Completion Date:	November 2015 (Final data collection date for primary outcome measure)